The New Zealand Formulary has prompted a rethink on dabigatran, in hopes of keeping stroke risk in check for people who have had deep vein thrombosis and/or pulmonary embolism
Several popular brands of cough medication may become prescription-only or pharmacist-only if a Medicines Classification Committee recommendation comes into force
Dietary supplements, Māori medicines and direct-to-consumer advertising have been left up in the air in a massive overhaul of controls on medicines and medical devices
Antiretroviral therapy use by an HIV-negative person is not new; post-exposure prophylaxis is common. Now, there is funding for pre-exposure prophylaxis in high-risk individuals. This article is a review of PrEP, as it applies locally, and of the role GPs can play
Two separate Ministerial Expert Advisory Groups have concluded that a rise in adverse reaction reporting to a commonly prescribed antidepressant is not caused by medicine safety or quality concerns
Specialist GP Nikki Vadgama provides some tips to make your next paediatric eczema consult easier. She includes a review of new guidelines, resources, websites and medications for paediatric eczema management